a–f, C57BL/6 mice bearing B16F10 tumours received ACT of PMEL T cells (5 × 106, i.v.) followed by administration of Fc–IL-4 (20 µg, p.t.) or PBS every other day for four doses. Mice were euthanized on day 14 and the tumour tissues were collected for analysis by flow cytometry. Data are a single representative of two independent experiments. All data represent mean ± s.e.m. Shown are the experimental timeline (a), cell counts of PMEL or endogenous CD8+ TILs (b) (n = 8 animals), representative flow cytometry plots showing the frequencies of tumour-infiltrating CD8+ TTE cells (PD-1+TIM-3+) among PMEL or endogenous CD8+ TILs (c), cell counts of three subpopulations among PMEL or endogenous CD8+ TILs (d) (n = 8 animals), and representative flow cytometry plots (e) and frequencies (f) of granzyme B+ and TNF+IFNγ+ among tumour-infiltrating CD8+ TTE cells (n = 5 animals). g–j, C57BL/6 mice bearing B16F10 tumours received ACT of PMEL T cells (5 × 106, i.v.) followed by administration of Fc–IL-4 (20 µg, p.t.) or PBS every other day for four doses in total. Mice were euthanized on day 14, tumour tissues were collected, and PMEL CD8+ T cells were sorted for scRNA-seq (n = 5 animals). g, UMAP clustering of all the PMEL CD8+ TILs. h, Indicated co-inhibitory gene marker expression on the UMAP. i, Comparison of cell proportion in each cluster. j, Comparison of functional gene expression in the terminally exhausted-like T cells. Statistical analyses are performed using two-sided unpaired Student’s t-test. Schematic in a created using BioRender (https://Biorender.com).
The type 2 cytokine Fc–IL-4 revitalizes exhausted CD8+ T cells against cancer
type 2 cytokine Fc-IL-4는 exhausted CD8+ T cell을 활성화하여 암에 대항한다 Abstract 현재의 암 면역 요법은 주로 암과 싸우는 type 1 면역 반응을 유도하는 데 중점을 두고 있지만, 장기적인 완전…
